- Home
- ATXS
as 10-24-2025 3:54pm EST
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 676.1M | IPO Year: | 2015 |
| Target Price: | $30.00 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.56 - $12.55 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | -74.39% |
Latest Astria Therapeutics Inc. News
ATXS Breaking Stock News: Dive into ATXS Ticker-Specific Updates for Smart Investing
Zacks
10 days ago
BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock?
MT Newswires
10 days ago
HC Wainwright Downgrades Astria Therapeutics to Neutral From Buy
Zacks
11 days ago
Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX
Pharmaceutical Technology
11 days ago
BioCryst to buy Astria Therapeutics for $700m in enterprise value
Simply Wall St.
11 days ago
How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals
MT Newswires
12 days ago
US Equity Markets Mixed After Fed Chair Hints at End of Quantitative Tightening Program
MT Newswires
12 days ago
Sector Update: Health Care Stocks Higher Late Afternoon
MT Newswires
12 days ago
Top Midday Decliners
Compare ATXS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATXS Astria Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.